🔗 Permalink

Inventor profile of:

Terry B. Strom

City:

Brookline, Massachusetts

Country:

United States

Published Applications:

Last publication date:

2019-09-12

Top Assignees for applications by Terry B. Strom

The entities that hold a legal rights for patent applications filed by inventor Strom Terry B.:

Beth Israel Deaconess Medical Center Inc. 14 Boston, MA United States
The General Hospital Corporation 2 Boston, MA United States
CORNELL RESEARCH FOUNDATION, INC. 2 Ithaca, NY United States
Children"s Medical Center Corporation 1 Boston, MA United States
Beth Israel Deaconess Medical Center 1 Boston, MA United States
THE BRIGHAM AND WOMEN'S HOSPITAL, INC. 1 Boston, MA United States

Recent patent applications by Strom Terry B.

Terry B. Strom from Brookline, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2019-09-12

US20190276516A1

Chemistry; metallurgy

α1-antitrypsin compositions and methods of treating autoimmune diseases

#2 | 2017-07-06

US20170190762A1

Chemistry; metallurgy

ALPHA1 -ANTITRYPSIN COMPOSITIONS AND METHODS OF TREATING AUTOIMMUNE DISEASES

#3 | 2017-03-09

US20170065688A1

Human necessities

COMPOSITIONS CONTAINING ALPHA-1-ANTITRYPSIN AND METHODS FOR USE

#4 | 2014-10-09

US20140303251A1

Human necessities

Methods Of Treating Acute Kidney Injury With Retinoic Acid

#5 | 2014-05-29

US20140147441A1

Chemistry; metallurgy

COMPOSITIONS CONTAINING ALPHA-1-ANTITRYPSIN AND METHODS FOR USE

#6 | 2013-02-14

US20130040301A1

Chemistry; metallurgy

Methods of Evaluating Transplant Rejection

#7 | 2011-01-27

US20110020367A1

Chemistry; metallurgy

Methods of Evaluating Transplant Rejection

#8 | 2011-01-27

US20110020269A1

Human necessities

METHODS AND COMPOSITIONS FOR MODIFYING T CELL IMMUNE RESPONSES AND INFLAMMATION

#9 | 2010-05-06

US20100111940A1

Human necessities

Compositions containing α-1-antitrypsin and methods for use

#10 | 2009-08-25

US10749699

Modulation of IL-2- and IL-15-mediated T cell responses

#11 | 2008-04-17

US20080089894A1

Human necessities

Transplant tolerance by costimulation blockade and T-cell activation-induced apoptosis

#12 | 2008-03-25

US10853466

Compositions and methods for achieving immune suppression

#13 | 2008-01-10

US20080008680A1

Physics

Antagonists of interleukin-15

#14 | 2007-08-30

US20070202125A1

Chemistry; metallurgy

Inhibiting rejection of a graft

#15 | 2007-08-21

US10245243

Antagonists of interleukin-15

#16 | 2007-05-31

US20070122806A1

Chemistry; metallurgy

Predicting graft rejection

#17 | 2007-04-12

US20070082356A1

Chemistry; metallurgy

Methods of evaluating transplant rejection

#18 | 2006-11-02

US20060246032A1

Human necessities

Chimeric IL-10

#19 | 2006-03-28

US10145517

Chimeric IL-10

#20 | 2006-03-16

US20060057680A1

Human necessities

Mutant interleukin-15 polypeptides

#21 | 2006-03-16

US20060057102A1

Human necessities

Mutant interleukin-15-containing compositions and suppression of an immune response

#22 | 2005-10-27

US20050240010A1

Physics

Nucleic acids encoding antagonists of interleukin-15

#23 | 2005-05-31

US9777732

Measurement of protective genes in allograft rejection

#24 | 2005-03-17

US20050058624A1

Human necessities

Chimeric IL-10 proteins and uses thereof

#25 | 2005-02-10

US20050031611A1

Human necessities

Transplant tolerance by costimulation blockade and T-cell activation-induced apoptosis

InventorID:

90175 ⎘